The British Irish Hearing Instrument Manufacturers Association data for Q1 2026 shows increases in ROI sales and UK private sales compared to Q4 2025, with a notable rise in rechargeable devices. The British Irish Hearing Instrument Manufacturers Association ( BIHIMA ) has released its hearing instrument sales data for the first quarter of 2026, indicating growth across the private UK market and the Republic of...
No actionable change — this is market sales data with no direct implication for clinical practice or patient care decisions.
Rising private-sector hearing aid sales in the UK and Ireland signal a growing consumer market, and the surge in rechargeable adoption reflects a lasting shift in patient device preference that clinic owners and dispensers should factor into their stock and counselling strategies.
- 01BIHIMA Q1 2026 private hearing aid sales in the UK reached approximately 145,500 units — the highest quarterly figure on the chart.
- 02Sales grew quarter-over-quarter from Q4 2025 (~129,300 units) to Q1 2026 (~145,500 units).
- 03Rechargeable hearing device adoption showed a notable increase within this sales period.
- 04Growth was reported across both the UK and Republic of Ireland private markets.
- 05The data covers private-pay sales only; NHS/public-sector volumes are not reflected.
UK and Republic of Ireland private hearing aid sales grew in Q1 2026 compared to Q4 2025.
press releasesupportedRechargeable hearing device adoption increased notably in Q1 2026.
press releasepartially supported